Clinical Trial

CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine

Study acronym: CMP-MYTHiC
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated April 20, 2026 (before its estimated May 2, 2026 completion). Its status may not reflect the trial's current state.
Summary
Two-parallel groups randomized, single-blinded, multi-center phase III controlled trial in patients with chronic inflammatory cardiomyopathy to assess the efficacy of colchicine and associated prospective registry to assess the prognostic value of positive genetic testing in this population.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-11-28; most recent amendment 2026-04-15.
Trial Details
NCT Number NCT06158698
Lead Sponsor Niguarda Hospital
Collaborators: European Union, Ministry of Health, Italy, Mario Negri Institute for Pharmacological Research, University of Milano Bicocca
Conditions Cardiomyopathies, Myocarditis, Inflammatory Cardiomyopathy, Heart Failure, Ventricular Arrythmia
Enrollment 80 participants
Start Date 2023-11-14
Primary Completion 2026-05-02 (estimated)
Study Completion 2028-05-02 (estimated)
Updated on ClinicalTrials.gov 2026-04-20